Bill Type
Congress Name
Long Title
AN ACT LOWERING THE COSTS OF MEDICINES AND HEALTH CARE IN THE PHILIPPINES BY EXEMPTING THE SALE, IMPORTATION, PROCESSING, REPACKING OR MANUFACTURING OF: MEDICINES, PHARMACEUTICAL PRODUCTS, MEDICAL, DENTAL AND HOSPITAL EQUIPMENT, AND RAW MATERIALS TOBE USED IN THE MANUFACTURE THEREOF FROM ALL DUTIES AND TAXES
Date filed
July 1, 1998
Scope
Urgent Bill
No
Legislative History
House Bill/Resolution NO. HB00076 | |
FULL TITLE : AN ACT LOWERING THE COSTS OF MEDICINES AND HEALTH CARE IN THE PHILIPPINES BY EXEMPTING THE SALE, IMPORTATION, PROCESSING, REPACKING OR MANUFACTURING OF: MEDICINES, PHARMACEUTICAL PRODUCTS, MEDICAL, DENTAL AND HOSPITAL EQUIPMENT, AND RAW MATERIALS TOBE USED IN THE MANUFACTURE THEREOF FROM ALL DUTIES AND TAXES | |
ABSTRACT : Grants exemption from duties and taxes on the raw materials used in the manufacture of medicines, pharmaceutical products, medical, dental and hospital equipment and on the sale, importation, processing, repacking or manufacturing of the same thereby making medicines and medical services AVAILABLE and more AFFORDABLE to the citizens. | |
PRINCIPAL AUTHOR/S : ROXAS, MANUEL A. | |
DATE FILED : 1998-07-01 | |
SIGNIFICANCE: NATIONAL | |
CO-AUTHORS : | |
1. | 2. |
3. | 4. |
5. | 6. |
7. | 8. |
9. | 10. |
11. | 12. |
13. | 14. |
15. | 16. |
17. | 18. |
19. | 20. |
21. | |
ADMINISTRATION BILL? No | |
URGENT BILL? No | |
ACTIONS TAKEN BY THE COMMITTEE ON RULES | |
REFERRAL TO THE COMMITTEE ON TRADE AND INDUSTRY ON 1998-07-28 | |
SECONDARILY REFERRED TO THE COMMITTEE(S) ON HEALTH, WAYS AND MEANS |
Abstract
Grants exemption from duties and taxes on the raw materials used in the manufacture of medicines, pharmaceutical products, medical, dental and hospital equipment and on the sale, importation, processing, repacking or manufacturing of the same thereby making medicines and medical services AVAILABLE and more AFFORDABLE to the citizens.
Disclaimer
Note: Legislative history and other information accessed from Congress Legis. Information as of April 20, 2022.